CDA | Evidence Driven
CDA | Evidence Driven

naloxagol

Details

Files
Generic Name:
naloxagol
Project Status:
Received
Therapeutic Area:
Management of opioid-induced constipation (OIC).
Manufacturer:
N/A
Call for patient/clinician input open:
Brand Name:
N/A
Project Line:
Reimbursement Review
Project Number:
SX0753-000
Call for patient/clinician input closed:
NOC Status at Filing:
N/A
Biosimilar:
No
Submission Type:
Non-sponsored Submission
Fee Schedule:
Pending
Indications:
Treatment of opioid-induced constipation (OIC) in adult patients with cancer and non-cancer pain who have had an inadequate response to laxative(s).
Key Milestones2
Submission received25-Nov-24

Files

Proposed Scope View PDF
Last Updated : November 26, 2024